수의용 치료제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Veterinary Therapeutics Market size is expected to reach USD 101.47 Billion in 2034 from USD 57.86 Billion (2025) growing at a CAGR of 6.44% during 2026-2034.

The global veterinary therapeutics market has grown steadily due to increasing attention to animal health and welfare. Rising pet ownership, expanding livestock industries, and the growing need to prevent and treat animal diseases have fueled demand for veterinary medicines and treatments. Veterinary therapeutics include vaccines, anti-infectives, parasiticides, and other pharmaceutical products designed to improve animal health. As animal healthcare systems become more advanced, the adoption of modern veterinary treatments has increased significantly across both developed and developing regions.

Market growth is driven by several factors, including the rising prevalence of animal diseases, the growing awareness of zoonotic diseases, and the need to ensure food safety in livestock production. Governments and agricultural organizations are promoting animal health programs to prevent disease outbreaks and improve productivity. Additionally, technological advancements in drug development and diagnostics are enabling more effective treatments. The increasing willingness of pet owners to spend on advanced veterinary care is also contributing to market expansion.

In the future, the veterinary therapeutics market is expected to expand further as research and innovation lead to new treatment options. Biotechnology and precision medicine are likely to play a larger role in developing targeted therapies for animals. Digital health technologies, including remote monitoring and tele-veterinary services, may also enhance veterinary care. As global demand for animal-derived food products rises and pet ownership continues to grow, the market for veterinary therapeutics will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Drugs
• Vaccines
• Medicated Feed Additives

By Animal Type

• Companion
• Livestock

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channels

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

COMPANIES PROFILED

• Zoetis, Intervet Inc Merck Animal Health, Elanco, Merial, Bayer AG, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol SA, IDEXX Laboratories Inc, Virbac
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY THERAPEUTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medicated Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Companion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Livestock Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY THERAPEUTICS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY THERAPEUTICS MARKET: BY DISTRIBUTION CHANNELS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channels
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmacies & Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY THERAPEUTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Animal Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channels
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Animal Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channels
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Animal Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channels
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Animal Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channels
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Animal Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channels
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Intervet Inc. (Merck Animal Health)
  • 10.2.3 Elanco
  • 10.2.4 Merial
  • 10.2.5 Bayer AG
  • 10.2.6 Boehringer Ingelheim International GmbH
  • 10.2.7 Ceva
  • 10.2.8 Vetoquinol S.A
  • 10.2.9 IDEXX Laboratories Inc
  • 10.2.10 Virbac